Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design

Johannes Boettcher, Bonnie Filter, Jonas Denecke, Amra Hot, Anne Daubmann, Antonia Zapf, Karl Wegscheider, Jan Zeidler, J-Matthias Graf von der Schulenburg, Monika Bullinger, Miriam Rassenhofer, Michael Schulte-Markwort, Silke Wiegand-Grefe, Johannes Boettcher, Bonnie Filter, Jonas Denecke, Amra Hot, Anne Daubmann, Antonia Zapf, Karl Wegscheider, Jan Zeidler, J-Matthias Graf von der Schulenburg, Monika Bullinger, Miriam Rassenhofer, Michael Schulte-Markwort, Silke Wiegand-Grefe

Abstract

Background: Families of children with rare diseases (i.e., not more than 5 out of 10,000 people are affected) are often highly burdened with fears, insecurities and concerns regarding the affected child and its siblings. Although families caring for children with rare diseases are known to be at risk for mental disorders, the evaluation of special programs under high methodological standards has not been conducted so far. Moreover, the implementation of interventions for this group into regular care has not yet been accomplished in Germany. The efficacy and cost-effectiveness of a family-based intervention will be assessed.

Methods/design: The study is a 2x2 factorial randomized controlled multicenter trial conducted at 17 study centers throughout Germany. Participants are families with children and adolescents affected by a rare disease aged 0 to 21 years. Families in the face-to-face intervention CARE-FAM, online intervention WEP-CARE or the combination of both will be treated over a period of roughly 6 months. Topics discussed in the interventions include coping, family relations, and social support. Families in the control condition will receive treatment as usual. The primary efficacy outcome is parental mental health, measured by the Structured Clinical Interview for DSM-IV (SCID-I) by blinded external raters. Further outcomes will be assessed from the parents' as well as the children's perspective. Participants are investigated at baseline, 6, 12 and 18 months after randomization. In addition to the assessment of various psychosocial outcomes, a comprehensive health-economic evaluation will be performed.

Discussion: This paper describes the implementation and evaluation of two family-based intervention programs for Children Affected by Rare Disease and their Family's Network (CARE-FAM-NET) in German standard care. A methodologically challenging study design is used to reflect the complexity of the actual medical care situation. This trial could be an important contribution to the improvement of care for this highly burdened group.

Trial registration: German Clinical Trials Register: DRKS00015859 (registered 18 December 2018) and ClinicalTrials.gov : NCT04339465 (registered 8 April 2020). Protocol Version: 15 August 2020 (Version 6.1). Trial status: Recruitment started on 1 January 2019 and will be completed on 31 March 2021.

Keywords: Family intervention; Internet-based intervention; Mental health; Randomized controlled trial; Rare diseases.

Conflict of interest statement

All authors declare that there are no competing interests.

Figures

Fig. 1
Fig. 1
Study design

References

    1. European Commission. Rare diseases [Internet]. 2005. Available from: . European Commission, European Union.
    1. Wetterauer B, Schuster R. Seltene Krankheiten - Probleme, Stand und Entwicklung der nationalen und europäischen Forschungsförderung [Rare diseases. Funding programs in Germany and Europe] Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz. 2008;51(5):519–528. doi: 10.1007/s00103-008-0524-7.
    1. EURORDIS. Rare diseases: understanding this public health priority [Internet]. 2005. Available from: . Accessed 08 October 2019.
    1. Frank M, Eidt-Koch D, Aumann I, Reimann A, Wagner TOF, von der Schulenburg JM. Maßnahmen zur Verbesserung der gesundheitlichen Situation von Menschen mit seltenen Erkrankungen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(10):1216–1223. doi: 10.1007/s00103-014-2040-2.
    1. Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet. 2010;152A(5):1136–1156. doi: 10.1002/ajmg.a.33380.
    1. van Oers HA, Haverman L, Limperg PF, van Dijk-Lokkart EM, Maurice-Stam H, Grootenhuis MA. Anxiety and depression in mothers and fathers of a chronically ill child. Matern Child Health J. 2014;18(8):1993–2002. doi: 10.1007/s10995-014-1445-8.
    1. Toly VB, Musil CM, Carl JC. A longitudinal study of families with technology-dependent children. Res Nurs Health. 2012;35(1):40–54. doi: 10.1002/nur.21454.
    1. Lavigne JV, Faier-Routman J. Psychological adjustment to pediatric physical disorders: a meta-analytic review. J Pediatr Psychol. 1992;17(2):133–157. doi: 10.1093/jpepsy/17.2.133.
    1. Limbers CA, Skipper S. Health-related quality of life measurement in siblings of children with physical chronic illness: a systematic review. Fam Syst Health. 2014;32(4):408. doi: 10.1037/fsh0000077.
    1. Morgenstern L, Wagner M, Denecke J, Grolle B, Johannsen J, Wegscheider K et al. Psychosozialer Unterstützungsbedarf von Eltern mit schwer chronisch somatisch erkrankten Kindern. Prax Kinderpsychol Kinderpsychiatr. 2017;66(9):687–701.
    1. Smith J, Cheater F, Bekker H. Parents’ experiences of living with a child with a long-term condition: a rapid structured review of the literature. Health Expect. 2015;18(4):452–474. doi: 10.1111/hex.12040.
    1. Anderson M, Elliott EJ, Zurynski Y. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8(1):22. doi: 10.1186/1750-1172-8-22.
    1. Mattejat F, Wüthrich C, Remschmidt H. Children of parents of psychiatric disorders. Examplary discusses of research perspectives in invastigations of children with depressiv parents. Nervenarzt. 2000;71:164–172. doi: 10.1007/s001150050025.
    1. Wiegand-Grefe S, Halverscheid S, Plass A. Kinder und ihre psychisch kranken Eltern: familienorientierte Prävention-der CHIMPs-Beratungsansatz. Göttingen: Hogrefe; 2011.
    1. Fidika A, Herle M, Lehmann C, Weiss C, Knaevelsrud C, Goldbeck L. A web-based psychological support program for caregivers of children with cystic fibrosis: A pilot study. Health Qual Life Outcomes. 2015;13(11).
    1. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Wiegand-Grefe S. Psychodynamische Interventionen in Familien mit chronischer Krankheit. Psychodynamische Interventionen in Familien mit chronischer Krankheit. Göttingen: Vandenhoeck & Ruprecht; 2017.
    1. West CA, Besier T, Borth-Bruhns T, Goldbeck L. Effectiveness of a family-oriented rehabilitation program on the quality of life of parents of chronically ill children. Klin Padiatr. 2009;221(4):241–246. doi: 10.1055/s-0029-1216364.
    1. Goldbeck L, Hölling I, Schlack R, West C, Besier T. The impact of an inpatient family-oriented rehabilitation program on parent-reported psychological symptoms of chronically ill children. Klin Pädiatrie. 2011;223(02):79–84. doi: 10.1055/s-0030-1262831.
    1. Seitz DCM, Knaevelsrud C, Duran G, Waadt S, Loos S, Goldbeck L. Efficacy of an internet-based cognitive-behavioral intervention for long-term survivors of pediatric cancer: a pilot study. Support Care Cancer. 2014;22(8):2075–2083. doi: 10.1007/s00520-014-2193-4.
    1. Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M. SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I. Göttingen: Hogrefe; 1997.
    1. Hinz A, Klaiberg A, Brähler E, König H. The quality of life questionnaire EQ−5D: Modelling and norm values for the general population. Psychother Psychosom Med Psychol. 2006;56(2):42–48. doi: 10.1055/s-2005-867061.
    1. Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19(6):887–897. doi: 10.1007/s11136-010-9649-x.
    1. Brooks R, Rabin R, De Charro F. The measurement and valuation of health status using EQ-5D. A European perspective. Evidence from the EuroQol BIO MED Research program. New York: Springer Science and Business Media; 2003. pp. 1–303.
    1. Goldbeck L, Storck M. Das Ulmer Lebensqualitäts-Inventar für Eltern chronisch kranker Kinder (ULQIE) Z Klin Psychol Psychother. 2002;31(1):31–39. doi: 10.1026/0084-5345.31.1.31.
    1. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003.
    1. DISABKIDS Group . The DISABKIDS questionnaires-quality of life questionnaires for children with chronic conditions. Lengerich: Pabst Science Publishers; 2006.
    1. The KIDSCREEN Group Europe . The KIDSCREEN questionnaires: quality of life questionnaires for children and adolescents. Lengerich: Pabst Science Publishers; 2006.
    1. Ravens-Sieberer U, Erhart M, Rajmil L, Herdman M, Auquier P, Bruil J, et al. Reliability, construct and criterion validity of the KIDSCREEN-10 score: a short measure for children and adolescents’ well-being and health-related quality of life. Qual Life Res. 2010;19(10):1487–1500. doi: 10.1007/s11136-010-9706-5.
    1. Bouwmans C, van Der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, et al. Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD. Eur J Health Econ. 2014;15(9):967–977. doi: 10.1007/s10198-013-0540-x.
    1. Franke H. Brief Symptom Inventory von L.R. Derogatis (Kurzform der SCL-90-R). Deutsche Version. Manual. Göttingen: Beltz Test Gesellschaft; 2000.
    1. Löwe B, Spitzer RL, Zipfel S, Herzog W. Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Autorisierte deutsche Version des “Prime MD Patient Health Questionnaire (PHQ)”. Karlsruhe: Pfizer; 2002.
    1. Saß H, Wittchen HU, Zaudig M, Houben I. Diganostisches und Statistisches Manual psychischer Störungen - Textrevision. Göttingen: Hogrefe; 2003.
    1. Delmo C, Weiffenbach O, Gabriel M, Stadler C, Poustka F. Diagnostisches Interview Kiddie-Sads-Present and Lifetime Version (K-SADS-PL). 5. Auflage der deutschen Forschungsversion, erweitert um ICD-10-Diagnostik. Frankfurt: linik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters; 2001. pp. 1–241.
    1. Steinhausen HC. Eine Skala zur Beurteilung psychisch gestörter Kinder und Jugendlicher. Z Kinder Jugendpsychiatr. 1985;13(3):230–240.
    1. Arbeitsgruppe Deutsche Child Behavior Checklist. Elternfragebogen über das Verhalten von Kindern und Jugendlichen; deutsche Bearbeitung der Child Behavior Checklist (CBCL/4–18). Einführung und Anleitung zur Handauswertung. 2. Auflage mit deutschen Normen, Bearbeitet von M. Döpfner, J. Plück, S. Böl. Cologne: Arbeitsgruppe Kinder-, Jugend- und Familiendiagnostik (KJFD). 1998.
    1. Arbeitsgruppe Deutsche Child Behavior Checklist. Fragebogen für Jugendliche; deutsche Bearbeitung des Youth Self Report (YSR) der Child Behavior Checklist. Einführung und Anleitung zur Handauswertung. 2. Auflage mit deutschen Normen, bearbeitet von M. Döpfner, J. Plück, S. Bölte, K. Lenz, P. Melchers & . Cologne: Arbeitsgruppe Kinder-, Jugend- und Familiendiagnostik (KJFD). 1998.
    1. McCubbin HI, McCubbin MA, Cauble E, Goldbeck L. Fragebogen zur elterlichen krankheitsbewältigung: coping health inventory for parents (CHIP)-deutsche version. Kindheit Entwicklung. 2001;10(1):28–35. doi: 10.1026//0942-5403.10.1.28.
    1. Spirito A, Stark LJ, Williams C. Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol. 1988;13(4):555–574. doi: 10.1093/jpepsy/13.4.555.
    1. Meltzer H. Development of a common instrument for mental health, i Novisky and Gudex (eds.) EUROHIS: Developing Common Instruments for Health Surveys. IOS Press. 2003.
    1. Bojanowski S, Riestock N, Nisslein J, Weschenfelder-Stachwitz H, Lehmkuhl U. Psychometric properties of the sibling relationship questionnaire in the German version (SRQ-deu) Psychother Psychosom Med Psychol. 2015;65(9):370–378.
    1. Hahlweg K. Fragebogen zur Partnerschaftsdiagnostik. 2., neu normierte und und erweiterte Auflage. Göttingen: Hogrefe; 2016.
    1. van Dyck Z, Hilbert A. Eating disorders in youth-questionnaire. Deutsche version. Leipzig: Universität Leipzig; 2016.
    1. Richter F, Strauß B, Berger U. Brief instruments in German for the assessment of disordered eating. Psychother Psychosom Med Psychol. 2018;68(3):99–108.
    1. von Gontard A, Lehmkuhle G. Leitfaden Enuresis. Göttingen: Hogrefe; 2009. pp. 126–128.
    1. Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC. Die deutsche Version des Client Sociodemographic and Service Receipt Inventory: Ein Instrument zur Erfassung psychiatrischer Versorgungskosten. Psychiatr Prax. 2001;28(2):84–90.
    1. Kilian R, Losert C, McDaid D, Park A, Knapp M, Beecham J, et al. The health economic evaluation of children and adolescent mental health services across the enlarged Europe. Ulm: Ulm University, Department of Psychiatry and Psychotherapy; 2009.
    1. Mattejat F, Remschmidt H. Fragebögen zur Beurteilung der Behandlung: FBB. Göttingen: Hogrefe; 1998.
    1. Schmidt J, Wittmann WW. ZUF-8. Fragebogen zur Messung der Patientenzufriedenheit. In: Brähler E, Schumacher J, Strauß B, editors. Diagnostische Verfahren in der Psychotherapie. Göttingen: Hogrefe; 2002. pp. 392–396.
    1. Strauss B, Strupp HH, Burgmeier-Lohse M, Wille H, Storm S. Deutschsprachige Version der Vanderbilt-Psychotherapie-Skalen: Beschreibung und Anwendung in zwei Kurztherapien. Zeitschrift Klin Psychol Psychopathol Psychother. 1992;40(4):411–30.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться